Evaxion Biotech AS (NAS:EVAX)
$ 2 -0.38 (-15.97%) Market Cap: 11.16 Mil Enterprise Value: 15.38 Mil PE Ratio: 0 PB Ratio: 200.00 GF Score: 21/100

Q2 2023 Evaxion Biotech A/S Earnings Call Transcript

Aug 22, 2023 / 02:00PM GMT
Release Date Price: $9.8 (+1.55%)
Operator

Good day, and thank you for standing by. Welcome to the Evaxion Biotech Q2 Results Call. (Operator Instructions)

Please be advised that today's conference is being recorded. I would now like to hand the conference over to your speaker today, Per Norlen. Please go ahead.

Per Goran Oskar Norlen;S;CEO
Evaxion Biotech A

/-

Thank you, operator. Good morning and good afternoon, everyone. I'm Per Norlen, Chief Executive Officer at Evaxion. And with me today is Jesper Nyegaard Nissen, Chief Operating Officer and Interim and Interim Chief Financial Officer at Evaxion since August 1.

First, before we start, a note on forward-looking statements, let me remind you that the following discussion contains certain statements that are considered forward-looking statements as defined in the Private Securities Litigation Reform Act of 1995. Because forward-looking statements involve risks and uncertainties, they are not guarantees of future performance, and actual results may differ materially from those expressed or implied by

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot